Yupei Liang
725 Wanping South Road
Longhua, 200032, China
Longhua, 200032, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 22 publications
SCFβ-TrCP targets Ajuba for degradation in a GSK3β-dependent manner in colorectal cancer.
Journal: Neoplasia (New York, N.Y.)
Published: November 29, 2024
SCFFBXW5-mediated degradation of AQP3 suppresses autophagic cell death through the PDPK1-AKT-MTOR axis in hepatocellular carcinoma cells.
Journal: Autophagy
Published: May 10, 2024
Tumor grade-associated genomic mutations in Chinese patients with non-small cell lung cancer.
Journal: Frontiers in oncology
Published: December 09, 2022
Camptothecin Inhibits Neddylation to Activate the Protective Autophagy Through NF-κB/AMPK/mTOR/ULK1 Axis in Human Esophageal Cancer Cells.
Journal: Frontiers in oncology
Published: February 23, 2021
Jujuboside B Inhibits the Proliferation of Breast Cancer Cell Lines by Inducing Apoptosis and Autophagy.
Journal: Frontiers in pharmacology
Published: February 17, 2021
Cullin3-TNFAIP1 E3 Ligase Controls Inflammatory Response in Hepatocellular Carcinoma Cells via Ubiquitination of RhoB.
Journal: Frontiers in cell and developmental biology
Published: October 14, 2020
SMPD3-ALK: A novel ALK fusion gene in lung adenocarcinoma.
Journal: Clinical genetics
Published: September 03, 2020
Tumor-associated antigen Prame targets tumor suppressor p14/ARF for degradation as the receptor protein of CRL2Prame complex.
Journal: Cell death and differentiation
Published: March 16, 2020
Neddylation inhibition activates the protective autophagy through NF-κB-catalase-ATF3 Axis in human esophageal cancer cells.
Journal: Cell communication and signaling : CCS
Published: December 12, 2019
Effective targeting of the ubiquitin-like modifier NEDD8 for lung adenocarcinoma treatment.
Journal: Cell biology and toxicology
Published: June 25, 2019
Validation of NEDD8-conjugating enzyme UBC12 as a new therapeutic target in lung cancer.
Journal: EBioMedicine
Published: May 11, 2019
Smart and dual-targeted BSA nanomedicine with controllable release by high autolysosome levels.
Journal: Colloids and surfaces. B, Biointerfaces
Published: April 05, 2019
Last Updated: 09/26/2026